BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27077040)

  • 1. Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing.
    Salvianti F; Rotunno G; Galardi F; De Luca F; Pestrin M; Vannucchi AM; Di Leo A; Pazzagli M; Pinzani P
    Biomol Detect Quantif; 2015 Sep; 5():23-9. PubMed ID: 27077040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).
    Palmirotta R; Lovero D; Silvestris E; Felici C; Quaresmini D; Cafforio P; Silvestris F
    Cancer Genomics Proteomics; 2017; 14(3):173-179. PubMed ID: 28446532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of a WGA-Free Molecular Tagging-Based NGS Protocol for CTCs Mutational Profiling.
    De Luca G; Cardinali B; Del Mastro L; Lastraioli S; Carli F; Ferrarini M; Calin GA; Garuti A; Mazzitelli C; Zupo S; Dono M
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
    De Luca F; Rotunno G; Salvianti F; Galardi F; Pestrin M; Gabellini S; Simi L; Mancini I; Vannucchi AM; Pazzagli M; Di Leo A; Pinzani P
    Oncotarget; 2016 May; 7(18):26107-19. PubMed ID: 27034166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform.
    Vanni I; Coco S; Truini A; Rusmini M; Dal Bello MG; Alama A; Banelli B; Mora M; Rijavec E; Barletta G; Genova C; Biello F; Maggioni C; Grossi F
    Int J Mol Sci; 2015 Dec; 16(12):28765-82. PubMed ID: 26633390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of genetic mutations in patients with breast cancer from Saudi Arabia using Ion AmpliSeq™ Cancer Hotspot Panel v.2.0.
    Messaoudi SA; Al Sharhan NA; Alharthi B; Babu SR; Alsaleh AB; Alasiri AM; Assidi M; Buhmeida A; Almawi WY
    Biomed Rep; 2022 Apr; 16(4):26. PubMed ID: 35251613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of circulating tumor cells using a novel workflow combining the CellSearch
    Neumann MH; Schneck H; Decker Y; Schömer S; Franken A; Endris V; Pfarr N; Weichert W; Niederacher D; Fehm T; Neubauer H
    Biotechnol Prog; 2017 Jan; 33(1):125-132. PubMed ID: 27126369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing of SNPs using the HID-Ion AmpliSeq™ Identity Panel on the Ion Torrent PGM™ platform.
    Guo F; Zhou Y; Song H; Zhao J; Shen H; Zhao B; Liu F; Jiang X
    Forensic Sci Int Genet; 2016 Nov; 25():73-84. PubMed ID: 27500651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing of human opioid receptor genes based on a custom AmpliSeq™ library and ion torrent personal genome machine.
    Kringel D; Lötsch J
    Clin Chim Acta; 2016 Dec; 463():32-38. PubMed ID: 27725223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-laboratory evaluation of SNP-based forensic identification by massively parallel sequencing using the Ion PGM™.
    Eduardoff M; Santos C; de la Puente M; Gross TE; Fondevila M; Strobl C; Sobrino B; Ballard D; Schneider PM; Carracedo Á; Lareu MV; Parson W; Phillips C
    Forensic Sci Int Genet; 2015 Jul; 17():110-121. PubMed ID: 25955683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of an NGS Approach for Diagnostic BRCA1/BRCA2 Mutation Testing.
    Dacheva D; Dodova R; Popov I; Goranova T; Mitkova A; Mitev V; Kaneva R
    Mol Diagn Ther; 2015 Apr; 19(2):119-30. PubMed ID: 25893891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients.
    Bingham C; Fernandez SV; Fittipaldi P; Dempsey PW; Ruth KJ; Cristofanilli M; Katherine Alpaugh R
    Breast Cancer Res Treat; 2017 Jun; 163(2):219-230. PubMed ID: 28271309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM
    Lampignano R; Yang L; Neumann MHD; Franken A; Fehm T; Niederacher D; Neubauer H
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a novel approach to circulating tumor cell isolation for cancer gene panel analysis in patients with breast cancer.
    Lee SJ; Lee CH; Choi SH; Ahn SH; Son BH; Lee JW; Yu JH; Kwon NJ; Lee WC; Yang KS; Lee DH; Han DY; Choi MS; Park PS; Lee HK; Kim MS; Lee J; Jeon BH
    Oncol Lett; 2017 May; 13(5):3025-3031. PubMed ID: 28521409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance and actionable mutational spectrum in oral squamous cell carcinoma.
    Jayaprakash C; Varghese VK; Jayaram P; Chakrabarty S; Kudva A; Ray S; Satyamoorthy K
    J Oral Pathol Med; 2020 May; 49(5):427-434. PubMed ID: 31845386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical Evaluation of an NGS Testing Method for Routine Molecular Diagnostics on Melanoma Formalin-Fixed, Paraffin-Embedded Tumor-Derived DNA.
    Mancini I; Simi L; Salvianti F; Castiglione F; Sonnati G; Pinzani P
    Diagnostics (Basel); 2019 Sep; 9(3):. PubMed ID: 31547467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single Circulating-Tumor-Cell-Targeted Sequencing to Identify Somatic Variants in Liquid Biopsies in Non-Small-Cell Lung Cancer Patients.
    Barbirou M; Miller A; Manjunath Y; Ramirez AB; Ericson NG; Staveley-O'Carroll KF; Mitchem JB; Warren WC; Chaudhuri AA; Huang Y; Li G; Tonellato PJ; Kaifi JT
    Curr Issues Mol Biol; 2022 Feb; 44(2):750-763. PubMed ID: 35723337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of serous ovarian carcinoma using a multigene next generation sequencing cancer panel approach.
    Ab Mutalib NS; Syafruddin SE; Md Zain RR; Mohd Dali AZ; Mohd Yunos RI; Saidin S; Jamal R; Mokhtar NM
    BMC Res Notes; 2014 Nov; 7():805. PubMed ID: 25404506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining.
    Campton DE; Ramirez AB; Nordberg JJ; Drovetto N; Clein AC; Varshavskaya P; Friemel BH; Quarre S; Breman A; Dorschner M; Blau S; Blau CA; Sabath DE; Stilwell JL; Kaldjian EP
    BMC Cancer; 2015 May; 15():360. PubMed ID: 25944336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells and cell-free tumor DNA analyses in urothelial cancer using the LiquidBiopsy platform.
    Kobayashi M; Abe H; Arai K; Murakami S; Kamai T
    Curr Urol; 2022 Jun; 16(2):99-106. PubMed ID: 36570364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.